Echo Street Capital Management’s Abiomed Inc ABMD Stock Holding History

Echo Street Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,102	Closed	-$359K	–	787
2021 Q3	$359K	Buy	1,102 +103	+10%	+$34.9K	﹤0.01%	492
2021 Q2	$312K	Buy	+999	New	+$306K	﹤0.01%	478
2020 Q3	–	Sell	-980	Closed	-$237K	–	394
2020 Q2	$237K	Buy	+980	New	+$197K	﹤0.01%	410

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Echo Street Capital Management's ABMD Position: Q4 2021 in Review

Echo Street Capital Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 1,102 shares — an estimated $359K sold.

Echo Street Capital Management first reported a position in ABMD in Q2 2020 and held it in 3 quarters. The position peaked at $359K in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

Echo Street Capital Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
Echo Street Capital Management sold 1,102 Abiomed Inc shares in Q4 2021, an estimated $359K.
Echo Street Capital Management first reported a position in Abiomed Inc in Q2 2020 and held it in 3 quarters.
Echo Street Capital Management's Abiomed Inc position peaked at $359K in Q3 2021.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Echo Street Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.